HealthSouth (HLS) Tops Q2 EPS by 2c, Beats on Revenues; Offers FY Guidance

HealthSouth (NYSE: HLS) reported Q2 EPS of $0.70, $0.02 better than the analyst estimate of $0.68. Revenue for the quarter came in at $981.3 million versus the consensus estimate of $973.57 million.

GUIDANCE:

HealthSouth sees Q3 2017 EPS of $2.64-$2.73, versus the consensus of $2.69. HealthSouth sees Q3 2017 revenue of $3.875-3.95 billion, versus the consensus of $3.92 billion.

For earnings history and earnings-related data on HealthSouth (HLS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c